Direct immunofluorescence demystified: Essential insights and recent advances for dermatologists

Indian J Dermatol Venereol Leprol. 2024 Aug 8:1-10. doi: 10.25259/IJDVL_95_2024. Online ahead of print.

Abstract

Direct immunofluorescence (DIF) is widely used in dermatopathology for the diagnosis of autoimmune blistering diseases (AIBDs), cutaneous vasculitis, and connective tissue disorders. Although it is easy and useful to perform, it needs technical expertise and experience for proper interpretation. The yield of DIF depends on multiple factors including the adequacy, transportation, storage, processing, and interpretation of the biopsy specimen. Effective collaboration between the dermatologist and dermatopathologist along with meticulous clinico-pathological correlation is crucial for accurately interpreting DIF in the appropriate clinical context. In this narrative review of DIF in dermatology, we discuss the indications of DIF, recent updates on the selection of optimum biopsy sites, basic techniques of DIF including the classical transport medium and its alternatives, processing and staining technique, patterns in various diseases, advancements such as serration pattern analysis, and latest recommendations on the use of DIF in cutaneous disorders.

Keywords: Direct immunofluorescence; autoimmune blistering diseases; cutaneous vasculitis; serration pattern.

Publication types

  • Review